ChemSpider ID 28527704 | ||
 | ||
Surotomycin is an investigational oral antibiotic. This antibiotic is under investigation by Merck & Co (who acquired Cubist Pharmaceuticals) for the treatment of life-threatening Diarrhea, commonly caused by the bacteria Clostridium difficile.
References
Surotomycin Wikipedia(Text) CC BY-SA